563 related articles for article (PubMed ID: 24681079)
41. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
Thabit AK; Housman ST; Burnham CD; Nicolau DP
J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
[TBL] [Abstract][Full Text] [Related]
42. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
Garey KW; Ghantoji SS; Shah DN; Habib M; Arora V; Jiang ZD; DuPont HL
J Antimicrob Chemother; 2011 Dec; 66(12):2850-5. PubMed ID: 21948965
[TBL] [Abstract][Full Text] [Related]
43. Clinical manifestations of Clostridium difficile infection in a medical center in Taiwan.
Lai CC; Lin SH; Tan CK; Liao CH; Huang YT; Hsueh PR
J Microbiol Immunol Infect; 2014 Dec; 47(6):491-6. PubMed ID: 23978490
[TBL] [Abstract][Full Text] [Related]
44. Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.
Pham VP; Luce AM; Ruppelt SC; Wei W; Aitken SL; Musick WL; Roux RK; Garey KW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6113-6. PubMed ID: 26195522
[TBL] [Abstract][Full Text] [Related]
45. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
[TBL] [Abstract][Full Text] [Related]
46. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
Cober ED; Malani PN
J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
[TBL] [Abstract][Full Text] [Related]
48. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.
van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ
Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357
[TBL] [Abstract][Full Text] [Related]
49. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
[TBL] [Abstract][Full Text] [Related]
50. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
[TBL] [Abstract][Full Text] [Related]
51. Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.
Kuntz JL; Smith DH; Petrik AF; Yang X; Thorp ML; Barton T; Barton K; Labreche M; Spindel SJ; Johnson ES
Perm J; 2016; 20(1):20-5. PubMed ID: 26845084
[TBL] [Abstract][Full Text] [Related]
52. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
53. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
54. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
[TBL] [Abstract][Full Text] [Related]
55. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
[TBL] [Abstract][Full Text] [Related]
57. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
58. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
59. Engaging patients in the prevention of health care-associated infections: a survey of patients' awareness, knowledge, and perceptions regarding the risks and consequences of infection with methicillin-resistant Staphylococcus aureus and Clostridium difficile.
Ottum A; Sethi AK; Jacobs E; Zerbel S; Gaines ME; Safdar N
Am J Infect Control; 2013 Apr; 41(4):322-6. PubMed ID: 22884494
[TBL] [Abstract][Full Text] [Related]
60. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics.
Tilton CS; Johnson SW
Am J Infect Control; 2019 Mar; 47(3):280-284. PubMed ID: 30318399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
